The pharmacological management of osteoporosis.

Amy E. Riek; Dwight A. Towler

The pharmacological management of osteoporosis.

Amy E. Riek
, Dwight A. Towler

Research output: Contribution to journal › Review article › peer-review

Abstract

Pharmacotherapy is effective in decreasing the incidence of osteoporotic fracture, morbidity, and mortality. This benefit is pronounced in patients at highest risk for fracture: those with prior osteoporotic fracture, very low bone mineral density, or receiving chronic corticosteroid treatment. We review the best pharmacotherapeutic options currently available for treating osteoporosis.

Original language	English
Pages (from-to)	118-123
Number of pages	6
Journal	Missouri Medicine
Volume	108
Issue number	2
State	Published - Mar 2011

Cite this

@article{01f1a224cf2547eca5a72dc7dc69610d,

title = "The pharmacological management of osteoporosis.",

abstract = "Pharmacotherapy is effective in decreasing the incidence of osteoporotic fracture, morbidity, and mortality. This benefit is pronounced in patients at highest risk for fracture: those with prior osteoporotic fracture, very low bone mineral density, or receiving chronic corticosteroid treatment. We review the best pharmacotherapeutic options currently available for treating osteoporosis.",

author = "Riek, \{Amy E.\} and Towler, \{Dwight A.\}",

year = "2011",

month = mar,

language = "English",

volume = "108",

pages = "118--123",

journal = "Missouri Medicine",

issn = "0026-6620",

number = "2",

}

TY - JOUR

T1 - The pharmacological management of osteoporosis.

AU - Riek, Amy E.

AU - Towler, Dwight A.

PY - 2011/3

Y1 - 2011/3

N2 - Pharmacotherapy is effective in decreasing the incidence of osteoporotic fracture, morbidity, and mortality. This benefit is pronounced in patients at highest risk for fracture: those with prior osteoporotic fracture, very low bone mineral density, or receiving chronic corticosteroid treatment. We review the best pharmacotherapeutic options currently available for treating osteoporosis.

AB - Pharmacotherapy is effective in decreasing the incidence of osteoporotic fracture, morbidity, and mortality. This benefit is pronounced in patients at highest risk for fracture: those with prior osteoporotic fracture, very low bone mineral density, or receiving chronic corticosteroid treatment. We review the best pharmacotherapeutic options currently available for treating osteoporosis.

UR - https://www.scopus.com/pages/publications/79958700007

M3 - Review article

C2 - 21568234

AN - SCOPUS:79958700007

SN - 0026-6620

VL - 108

SP - 118

EP - 123

JO - Missouri Medicine

JF - Missouri Medicine

IS - 2

ER -

The pharmacological management of osteoporosis.

Abstract

Other files and links

Fingerprint

Cite this